Ladenburg Thalmann Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $346K | Sell |
2,320
-710
| -23% | -$106K | ﹤0.01% | 2102 |
|
2019
Q3 | $389K | Buy |
3,030
+1,379
| +84% | +$177K | ﹤0.01% | 1960 |
|
2019
Q2 | $233K | Buy |
1,651
+595
| +56% | +$84K | ﹤0.01% | 2358 |
|
2019
Q1 | $150K | Sell |
1,056
-54
| -5% | -$7.67K | ﹤0.01% | 2605 |
|
2018
Q4 | $138K | Buy |
1,110
+105
| +10% | +$13.1K | ﹤0.01% | 2520 |
|
2018
Q3 | $168K | Buy |
1,005
+426
| +74% | +$71.2K | ﹤0.01% | 2444 |
|
2018
Q2 | $86K | Hold |
579
| – | – | ﹤0.01% | 2847 |
|
2018
Q1 | $86K | Sell |
579
-1,391
| -71% | -$207K | ﹤0.01% | 2847 |
|
2017
Q4 | $265K | Buy |
1,970
+224
| +13% | +$30.1K | ﹤0.01% | 2004 |
|
2017
Q3 | $255K | Buy |
1,746
+1,551
| +795% | +$227K | ﹤0.01% | 1917 |
|
2017
Q2 | $31K | Sell |
195
-94
| -33% | -$14.9K | ﹤0.01% | 3335 |
|
2017
Q1 | $42K | Buy |
289
+172
| +147% | +$25K | ﹤0.01% | 3036 |
|
2016
Q4 | $13K | Sell |
117
-628
| -84% | -$69.8K | ﹤0.01% | 3735 |
|
2016
Q3 | $91K | Sell |
745
-23
| -3% | -$2.81K | ﹤0.01% | 2319 |
|
2016
Q2 | $109K | Sell |
768
-229
| -23% | -$32.5K | ﹤0.01% | 2098 |
|
2016
Q1 | $130K | Sell |
997
-161
| -14% | -$21K | ﹤0.01% | 1892 |
|
2015
Q4 | $163K | Buy |
1,158
+404
| +54% | +$56.9K | ﹤0.01% | 1717 |
|
2015
Q3 | $100K | Sell |
754
-660
| -47% | -$87.5K | ﹤0.01% | 1987 |
|
2015
Q2 | $249K | Sell |
1,414
-324
| -19% | -$57.1K | ﹤0.01% | 1449 |
|
2015
Q1 | $300K | Sell |
1,738
-448
| -20% | -$77.3K | 0.01% | 1318 |
|
2014
Q4 | $359K | Buy |
2,186
+486
| +29% | +$79.8K | 0.01% | 1093 |
|
2014
Q3 | $273K | Buy |
1,700
+638
| +60% | +$102K | 0.01% | 1062 |
|
2014
Q2 | $156K | Sell |
1,062
-18
| -2% | -$2.64K | ﹤0.01% | 1333 |
|
2014
Q1 | $150K | Buy |
1,080
+39
| +4% | +$5.42K | ﹤0.01% | 1276 |
|
2013
Q4 | $132K | Sell |
1,041
-370
| -26% | -$46.9K | ﹤0.01% | 1299 |
|
2013
Q3 | $130K | Buy |
1,411
+511
| +57% | +$47.1K | ﹤0.01% | 1242 |
|
2013
Q2 | $62K | Buy |
+900
| New | +$62K | ﹤0.01% | 1577 |
|